New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
11:37 EDTGPI, MHFI, OPEN, EXPR, TSRA, REY, GES, SYY, ARWRHigh option volume stocks
High option volume stocks: REY OPEN URA ARWR TSRA MHFI SYY EXPR GPI GES
News For REY;OPEN;ARWR;TSRA;MHFI;SYY;EXPR;GPI;GES From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
10:17 EDTTSRAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:03 EDTTSRATessera initiated with a Buy at Benchmark Co.
Target $44.
December 15, 2014
09:25 EDTGPIGroup 1 Automotive downgraded to Neutral from Buy at Sidoti
Subscribe for More Information
07:33 EDTARWRArrowhead submits IND for ARC-520 to begin Phase 2b studies
Arrowhead Research announced that it submitted an Investigational New Drug application to the U.S. Food and Drug Administration for ARC-520, itís drug candidate for the treatment of chronic hepatitis B virus infection. Arrowhead plans to submit additional clinical trial authorization applications with regulatory authorities in various jurisdictions in Europe and Asia. Pending national regulatory review and approval, Arrowhead intends to initiate two Phase 2b, multicenter, randomized, double-blind, placebo-controlled, multi-dose studies to determine the depth of hepatitis B surface antigen reduction following ARC-520 injection in combination with entecavir or tenofovir in patients with chronic immune active HBV infection. The Heparc-2002 study is planned to include patients who are negative for hepatitis B e-antigen at screening and the Heparc-2003 study is planned to include patients who are positive for HBeAg at screening. The primary objective is to evaluate the depth of HBsAg decline in response to multiple doses of ARC-520 compared to placebo in patients with chronic HBV infection as a measure of drug activity. Secondary objectives are to assess measures of safety and tolerability and to evaluate multi-dose pharmacokinetics of ARC-520 in patients with chronic HBV infection when co-administered with a fixed dose of entecavir or tenofovir, in addition to other exploratory safety and pharmacodynamic objectives.
December 11, 2014
13:09 EDTARWRArrowhead mentioned positively by Agora Financial
Agora Financial believes investors can "double [their] money ó virtually overnight." and have a "realistic chance" to make "up to 10 times [their] money" by investing in Arrowhead Research, according to a new research report from the firm. Arrowhead shares are up nearly 10% to $5.98 in afternoon trading. Reference Link
12:08 EDTSYYSysco near completion of US Foods buyout, NY Post reports
Subscribe for More Information
December 10, 2014
14:57 EDTTSRAAmkor Technology motion to overturn ruling in Tessera suit denied
Subscribe for More Information
10:20 EDTEXPROptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTTSRAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with an Underperform at Longbow... AutoZone (AZO) initiated with a Buy at Nomura... C.H. Robinson (CHRW) initiated with a Neutral at Nomura... CSX (CSX) initiated with a Buy at Nomura... CVS Health (CVS) initiated with a Neutral at Citigroup... Canadian National (CNI) initiated with a Neutral at Nomura... Carrizo Oil & Gas (CRZO) initiated with a Buy at Canaccord... CenterPoint Energy (CNP) initiated with a Neutral at Nomura... Con-way (CNW) initiated with a Neutral at Nomura... Cornerstone OnDemand (CSOD) initiated with a Buy at BofA/Merrill... Depomed (DEPO) initiated with an Outperform at RBC Capital... Dollar General (DG) initiated with a Buy at Citigroup... Dollar Tree (DLTR) initiated with a Neutral at Citigroup... Dynagas LNG (DLNG) initiated with a Buy at ABN Amro... EMC (EMC) initiated with a Neutral at JPMorgan... Energy Focus (EFOI) initiated with a Buy at Roth Capital... Expeditors (EXPD) initiated with a Neutral at Nomura... GasLog (GLOG) initiated with a Buy at ABN Amro... Genesee & Wyoming (GWR) initiated with a Neutral at Nomura... Golar LNG (GLNG) initiated with a Sell at ABN Amro... HII Technologies (HIIT) initiated with a Buy at Roth Capital... Hudbay Minerals (HBM) initiated with an Overweight at Barclays... J.B. Hunt (JBHT) initiated with a Buy at Nomura... Kansas City Southern (KSU) initiated with a Buy at Nomura... Kroger (KR) initiated with a Buy at Citigroup... Lear (LEA) initiated with a Buy at Northcoast... Lundin Mining (LUNMF) initiated with an Overweight at Barclays... NetApp (NTAP) initiated with a Neutral at JPMorgan... Norfolk Southern (NSC) initiated with a Neutral at Nomura... PROS (PRO) initiated with an Outperform at Pacific Crest... Qlik Technologies (QLIK)initiated with a Buy at BofA/Merrill... Rentokil (RTOKY) initiated with a Neutral at UBS... Revolution Lighting (RVLT) initiated with a Buy at Roth Capital... ServiceNow (NOW) initiated with a Buy at BofA/Merrill... Stratasys (SSYS) initiated with a Neutral at Longbow... Suburban Propane (SPH) initiated with a Hold at Stifel... Tableau (DATA) initiated with a Buy at BofA/Merrill... Teekay LNG (TGP) initiated with a Buy at ABN Amro... Tessera (TSRA) initiated with a Buy at Sidoti... Union Pacific (UNP) initiated with a Buy at Nomura... Viper Energy (VNOM) initiated with a Buy at Stifel... Visteon (VC) initiated with a Buy at Northcoast... Walgreen (WAG) initiated with a Buy at Citigroup... Werner (WERN) initiated with a Neutral at Nomura.
08:28 EDTTSRATessera initiated with a Buy at Sidoti
Subscribe for More Information
December 9, 2014
11:09 EDTMHFIMcGraw Hill Financial open to 'reasonable settlements' with DoJ and states
11:06 EDTMHFIMcGraw Hill Financial says trending to 36% margins this year
Subscribe for More Information
10:34 EDTMHFIMcGraw Hill Financial backs FY14 EPs view $3.78-$3.83, consensus $3.86
Subscribe for More Information
08:34 EDTMHFIMcGraw Hill Financial CMBS suspension company specific, says UBS
Subscribe for More Information
December 8, 2014
15:49 EDTMHFISEC seeks to suspend S&P from rating CMBS, Bloomberg reports
In what would be the SEC's toughest action yet against a major credit rater, the commission is seeking to suspend Standard & Poorís from rating commercial mortgage bonds, but its parent company McGraw Hill Financial remains in talks over a possible settlement, according to Bloomberg, citing a person with knowledge of the matter. Shares of McGraw Hill Financial are down 1.6% to $92.21 following Bloomberg's report. Reference Link
15:42 EDTMHFISEC seeks to suspend S&P from rating CMBS, Bloomberg says
Subscribe for More Information
10:20 EDTEXPROptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use